Arax Advisory Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10
| Closed | -$10 | – | 2587 |
|
|
2024
Q1 | $10 | Hold |
10
| – | – | ﹤0.01% | 1308 |
|
|
2023
Q4 | $21 | Hold |
10
| – | – | ﹤0.01% | 1325 |
|
|
2023
Q3 | $37 | Sell |
10
-9
| -47% | -$33 | ﹤0.01% | 1310 |
|
|
2023
Q2 | $89 | Hold |
19
| – | – | ﹤0.01% | 1254 |
|
|
2023
Q1 | $89 | Hold |
19
| – | – | ﹤0.01% | 1253 |
|
|
2022
Q4 | $85 | Sell |
19
-309
| -94% | -$1.38K | ﹤0.01% | 1253 |
|
|
2022
Q3 | $6K | Sell |
328
-1,769
| -84% | -$32.4K | ﹤0.01% | 775 |
|
|
2022
Q2 | $106K | Hold |
2,097
| – | – | 0.02% | 308 |
|
|
2022
Q1 | $296K | Hold |
2,097
| – | – | 0.04% | 184 |
|
|
2021
Q4 | $359K | Hold |
2,097
| – | – | 0.05% | 164 |
|
|
2021
Q3 | $1.04M | Hold |
2,097
| – | – | 0.14% | 69 |
|
|
2021
Q2 | $1.05M | Buy |
+2,097
| New | +$1.05M | 0.14% | 68 |
|
|
2020
Q4 | $979K | Hold |
2,052
| – | – | 0.14% | 60 |
|
|
2020
Q3 | $589K | Hold |
2,052
| – | – | 0.1% | 77 |
|
|
2020
Q2 | $392K | Sell |
2,052
-3,842
| -65% | -$734K | 0.07% | 91 |
|
|
2020
Q1 | $734K | Buy |
+5,894
| New | +$734K | 0.17% | 62 |
|